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The balance between the production and removal of cGMP in coronary vascular smooth muscle is of critical importance in determining coronary vasomotor tone and thus in the regulation of coronary blood flow. cGMP production by soluble guanylyl cyclase is activated by nitric oxide (NO), whereas cGMP breakdown occurs through phosphodiesterase 5 (PDE5). We hypothesized that myocardial infarction (MI) alters the balance between the production and removal of cGMP in the coronary vasculature and thereby alters the control of coronary vasomotor tone. Chronically instrumented swine with and without a 2-wk-old MI were exercised on a treadmill in the absence and presence of the PDE5 inhibitor EMD-360527 (300 g·kg Ϫ1 ·min Ϫ1 iv). Inhibition of PDE5 produced coronary resistance vessel dilation, which was more pronounced at rest than during exercise in normal swine. PDE5 gene expression was markedly reduced in coronary resistance vessels isolated from the remote myocardium of MI swine, which was accompanied by a similarly marked attenuation of coronary vasodilation by PDE5 inhibition in MI swine. The coronary vasoconstriction produced by inhibition of NO synthesis with N -nitro-L-arginine (20 mg/kg iv) was only slightly smaller in swine with MI. Interestingly, inhibition of NO synthesis reduced the vasodilator response to subsequent PDE5 inhibition in normal swine but not in MI swine. Conversely, PDE5 inhibition enhanced the coronary vasoconstriction produced by NO synthesis inhibition in normal swine but not in MI swine, suggesting that downregulation of PDE5 mitigated the loss of NO vasodilator influence. In conclusion, the expression and vasoconstrictor influence of PDE5 are markedly attenuated in coronary resistance vessels in the remote myocardium after MI, which appears to serve as a compensatory mechanism to mitigate the loss of NO vasodilator influence. coronary circulation; myocardial infarction; nitric oxide; phosphodiesterase 5; vasodilation LEFT VENTRICULAR (LV) function critically depends on an adequate oxygenation of the myocardium. Since myocardial O 2 extraction (ME O 2 ) is already high under resting conditions, any substantial increase in myocardial O 2 demand must be met by an increase in O 2 supply and hence an increase in coronary blood flow (CBF) (15, 20) . This tight matching of CBF to myocardial metabolism is the result of a delicate balance between a myriad of vasomotor signals stemming from cardiomyocytes, autonomic nerve terminals, and the endothelium (11, 15, 20, 56) .
The endothelium-derived vasodilator nitric oxide (NO) produces coronary vasodilation through the activation of soluble guanylyl cyclase (sGC) and formation of cGMP in vascular smooth muscle (21) . cGMP signaling is terminated through breakdown of cGMP by phosphodiesterase 5 (PDE5) and, to a lesser extent, by PDE1 (46) . The role of PDE5 in the regulation of coronary vascular tone at rest and during exercise in the normal heart is incompletely understood. Thus, PDE5 inhibition resulted in an increase in the diameter of large coronary arteries in awake resting swine (1), whereas it had no effect on coronary resistance vessel tone in dogs either at rest or during exercise (6) . An explanation for these divergent observations in porcine conduit and cane resistance vessels could be that the vasoconstrictor influence of PDE5 depends critically on the species or coronary vessel diameter studied or the degree of endogenous cGMP production (21) . The latter is supported by observations in isolated vessels showing that vasodilation produced by PDE5 inhibition was blunted by endothelial NO synthase (eNOS) inhibition (50, 52) . Importantly, eNOS inhibition resulted in coronary resistance vessel constriction in awake swine (16, 28, 32) and humans (19, 37, 44) but had little (57) or no effect on coronary resistance vessel tone in awake dogs (3, 55) . These observations suggest that the contribution of the NO-cGMP pathway to the regulation of coronary vasomotor tone varies between species and hence that, in contrast to dogs, PDE5 could potentially exert a significant coronary vasoconstrictor influence in the porcine and human coronary microvasculature. Therefore, the first aim of the present study was to determine the effects of PDE5 inhibition on the coronary circulation of awake, healthy swine at rest and during exercise and to study its dependency on eNOS activity.
Endothelial dysfunction, characterized by a lower NO bioavailability, is typically observed in patients with congestive heart failure (22) . Similarly, in swine with LV dysfunction secondary to a 2-to 3-wk-old myocardial infarction (MI), the contribution of NO to coronary resistance vessel tone in the remote myocardium at rest and during exercise (9) as well as the NO-dependent vasodilator response to agonists (28) were blunted. Loss of NO bioavailability and hence decreased production of cGMP could result in a reduced vasoconstrictor influence of PDE5. Consequently, the second aim of the present study was to study the effect of PDE5 inhibition on coronary resistance vessel tone in the remote myocardium after MI and to study the contribution of blunted eNOS activity in this process.
METHODS
Experiments were performed in accordance with the "Guiding Principles in the Care and Use of Vertebrate Animals in Research and Training" as approved by the Council of the American Physiological Society and with approval of the Animal Care Committee of Erasmus Medical Center Rotterdam. A total of 56 crossbred Landrace-Yorkshire swine of either sex (2-3 mo old) were entered into the study.
Surgical Procedures
Swine (22 Ϯ 1 kg at the time of surgery) were sedated (20 mg/kg im ketamine and 1 mg/kg im midazolam), anesthetized (15 mg/kg iv thiopental), intubated, and ventilated with a mixture of O 2 and N2 (1:2) to which 0.2-1.0% (vol/vol) isoflurane was added (16) . Anesthesia was maintained with midazolam (2 mg/kg ϩ 1 mg·kg Ϫ1 ·h Ϫ1 iv) and fentanyl (10 g·kg Ϫ1 ·h Ϫ1 iv). Swine were instrumented under sterile conditions, as previously described (16, 42) . Briefly, a thoracotomy was performed in the fourth left intercostal space. Subsequently, a polyvinylchloride catheter was inserted into the aortic arch for the measurement of mean aortic pressure and blood sampling for the determination of PO 2, PCO2, and pH (ABL 505, Radiometer) as well as O2 saturation and hemoglobin concentration (OSM3, Radiometer). A fluid-filled catheter and a high-fidelity Konigsberg pressure transducer were inserted into the LV via the apex. Fluid-filled catheters were also implanted into the left atrium for pressure measurements and in the pulmonary artery for the infusion of drugs. A small angiocatheter was inserted into the anterior interventricular vein for coronary venous blood sampling (16) . Finally, a transit-time flow probe (Transonic Systems) was placed around the left anterior descending coronary artery (LAD) for the measurement of CBF (41) .
In all 56 swine the proximal part of the left coronary circumflex artery (LCx) was exposed, but in only 26 animals the LCx was permanently occluded during surgery with a silk suture to produce a MI (27, 28) . Three MI swine died during surgery due to recurrent fibrillation. Electrical wires and catheters were tunneled subcutaneously to the back, the chest was closed, and animals were allowed to recover. Animals received analgesia (0.3 mg im buprenorphine for 2 days) and antibiotic prophylaxis (25 mg/kg iv amoxicillin and 5 mg/kg iv gentamycin for 5 days). Three MI swine died overnight after surgery. All catheters were flushed daily with heparinized saline (1,000 -5,000 IU/ml saline) to prevent clotting of the catheters.
Experimental Protocols
Experiments were performed ϳ2 wk after surgery, with animals exercising on a motor-driven treadmill. We have previously shown excellent reproducibility of the hemodynamic response in consecutive bouts of exercise in both normal swine (16) and MI swine (28) .
PDE5 inhibition. After hemodynamic measurements (lying and standing), blood samples (lying), and rectal temperature (standing) had been obtained, swine were subjected to an exercise protocol on a motor-driven treadmill (1-5 km/h for normal swine and 1-4 km/h for MI swine). Hemodynamic variables were continuously recorded, and blood samples were collected during the last 60 s of each 3-min exercise stage, at a time when hemodynamics had reached a steady state. After 90 min of rest, the PDE5 inhibitor EMD-360527 (a gift from Merck, Darmstadt, Germany) was administered to 12 normal swine and 8 MI swine by an infusion of 300 g·kg Ϫ1 ·min Ϫ1 iv, and the exercise protocol was repeated. We have previously demonstrated that this dose of EMD-360527 produces significant systemic and pulmonary vasodilation (34) . EMD-360527 demonstrates at least 45-fold selectivity for PDE5 (IC 50: 0.007 M) compared with PDE6 (IC50: 0.32 M), 94-fold selectivity for PDE1 (IC50: 0.66 M), 137-fold selectivity for PDE10 (IC50: 0.96 M), and Ͼ1,400-fold selectivity for PDE2, PDE3, PDE4, and PDE7 (all IC50 Ͼ 10 M) (34) . In these assays, PDE1-PDE4 was from guinea pig heart muscle, PDE5 was from human thrombocytes, and PDE6 was from the bovine retina, whereas PDE7 and PDE10 were obtained by expression of cDNA in COS-7 cells and Esherichia coli respectively.
Endothelial NOS inhibition. On a different day, a control exercise protocol was performed, as described above. After 90 min of rest, the eNOS inhibitor N -nitro-L-arginine (L-NNA) was administered at a dose of 20 mg/kg iv to 30 normal swine and 20 MI swine, and the exercise protocol was repeated (16, 28) . The results from this large group of swine also contain historical data of swine with and without MI used in other studies in which L-NNA was administered (9, 16, 28, 43) .
PDE5 inhibition in the presence of eNOS inhibition. Nine normal and six MI swine that had undergone a control exercise protocol and an exercise protocol in the presence of L-NNA were allowed to rest for another 90 min, after which they received the PDE5 inhibitor EMD-360527 and were subjected to a third exercise protocol.
Quantitative Real-Time PCR Analysis
Coronary small arteries isolated from the LAD perfusion territory of a separate group of six sham swine and four swine in which MI had been induced 5 wk before death were used for the detection of PDE5 mRNA (sense: 5=-TGGTGAACCCTTGAACATCA-3= and antisense: 5=-GT-GAATGTCCCACCATTTCC-3=). RNA was extracted from 4 -6 frozen vessel samples/group using a Qiagen RNA kit. cDNA was synthesized from 100 ng total RNA with iScript Reverse Transcriptase (Bio-Rad). Quantitative real-time PCR (MyIQ, Bio-Rad) was performed with SYBR green (Bio-Rad) (62) . Target gene mRNA levels were expressed relative to the housekeeping gene GAPDH as an endogenous control (39) .
Data Analysis
Digital recording and offline analysis of hemodynamic data and computation of myocardial O 2 consumption (MV O2) have been described in detail elsewhere (16) . Myocardial O2 delivery (MDO 2 ) to the region of myocardium perfused by the LAD was computed as the product of CBF and arterial blood O2 content. MV O2 was calculated as the product of CBF and the difference in O2 content between Heart rate, beats/min arterial and coronary venous blood. MEO 2 was computed as the ratio of MV O2 and MDO 2 (16) .
Statistical Analysis
Statistical analysis of hemodynamic data was performed using three-way (MI, drug treatment, and exercise) or two-way (MI and exercise) ANOVA for repeated measures, as appropriate. When significant effects were detected, post hoc testing for the effects of exercise, drug treatment, and MI was performed using Scheffé's test, followed by paired t-tests. To test for the effects of MI and drug treatment on the relation between MV O2 and MDO 2 , coronary venous O2 tension (CVPO 2 ), coronary venous O2 saturation (CVSO 2 ), or MEO 2 , regression analysis was performed with animals as a dummy variable and MI, drug treatment, and MV O2 as independent variables. Interaction terms (drug treatment and/or MI ϫ MV O2) were used to interpret alterations in the effect of drug treatment and/or MI during exercise. Linearity of the relations was confirmed by plotting the predicted value of the dependent variable against the residual value (measured value Ϫ predicted value). In all cases, residuals were scattered around zero over the entire range of predicted values.
An unpaired t-test was used to compare mRNA between normal and MI swine. Statistical significance was accepted when P Յ 0.05. Data are presented as means Ϯ SE.
RESULTS

Myocardial O 2 Balance in Normal and MI Swine
In normal swine, exercise resulted in an increase in heart rate and LV contractility, which was accompanied by a parallel increase in MV O 2 ( Fig. 1, and Table 1 ). The latter was met by an equivalent increase in CBF and hence MD O 2 , such that ME O 2 , CV PO 2 , and CV SO 2 remained essentially unchanged (Fig. 1) . MI of the LCx region increased the workload of the surviving myocardium (27, 58) , which together with the increase in heart rate produced a trend toward an increase in resting MV O 2 in the LAD area (Fig. 1) . The increased myocardial O 2 demand in MI swine was principally met by an increase in LAD flow (Table 1 and Fig. 2 ) but also by a small increase in ME O 2 , resulting in slightly lower levels of CV PO 2 and CV SO 2 in MI swine compared with normal swine, both at rest and during exercise (Fig. 1) .
Vasoconstrictor Influence of PDE5 in Coronary Resistance Vessels
PDE5 inhibition resulted in a decrease in blood pressure (Fig. 2) , reflecting systemic vasodilation (34) that was accompanied by a probably baroreceptor reflex mediated increase in heart rate ( Table 1) . In normal swine, PDE5 inhibition resulted in coronary vasodilation, as evidenced by a decrease in coronary vascular resistance (Table 1 and Fig. 2 ). This vasodilation resulted in an increase in CBF and MD O 2 , so that ME O 2 decreased, resulting in an increased CV PO 2 and CV SO 2 (Fig. 3) . The increase in MD O 2 in response to PDE5 inhibition was similar at rest and during exercise, whereas the increases in CV PO 2 and CV SO 2 were progressively attenuated during incremental levels of exercise (Fig. 3) .
The hemodynamic responses to PDE5 inhibition in MI swine were similar to those in normal swine. Thus, PDE5 inhibition produced a decrease in mean aortic blood pressure (Fig. 2) , which was accompanied by an elevation in heart rate ( Table 1 ). Yet, the decrease in ME O 2 as well as the increases in MD O 2 , CV PO 2 , and CV SO 2 in response to PDE5 inhibition was significantly smaller in MI swine compared with normal swine (Fig. 3) . Moreover, in contrast to normal swine, these responses to PDE5 inhibition in MI swine were maintained during exercise. Consistent with the reduced vasodilator response to PDE5 inhibition, mRNA for PDE5 was markedly reduced in coronary small arteries isolated from the remote territory of swine with MI compared with normal swine (Fig. 4) .
Integrated Control of Coronary Resistance Vessel Tone by eNOS and PDE5
In agreement with recent observations in our laboratory (9) , the increase in ME O 2 and the decreases in MD O 2 , CV PO 2 , and CV SO 2 produced by eNOS inhibition were slightly but significantly smaller in MI swine compared with normal swine (Fig. 5) .
Thus, coronary vasoconstriction in response to eNOS inhibition was blunted in MI swine, consistent with a reduction in NO bioavailability after MI. To investigate the integrated control of coronary resistance vessel tone by eNOS and PDE5, we studied the effects of PDE5 inhibition in a subgroup of animals after prior inhibition of eNOS with L-NNA. The vasodilator response to PDE5 inhibition was significantly attenuated by L-NNA in normal swine, as evidenced by blunted increases in MD O 2 , CV PO 2 , and CV SO 2 as well as a reduced decrease in ME O 2 compared with its effect under control conditions (compare Figs. 3 and 6 ). These results indicate that NO is an important source of cGMP in normal swine. In contrast, the coronary vasodilation in response to PDE5 inhibition was minimally affected by pretreatment with L-NNA in MI swine (compare Figs. 3 and 6 ), indicating that other factors are principally responsible for GC activation in MI swine.
To enable a comparison of the effects of L-NNA in the absence and presence of PDE5 inhibition, we plotted in Fig. 7 the relation between MD O 2 and CV SO 2 during PDE5 inhibition (from Fig. 3 ) and during L-NNA ϩ PDE5 inhibition (from Fig.  6 ) and compared it with the relations during control and L-NNA treatment (both from Fig. 5 ). The results demonstrate that the shift in the relations between MV O 2 and ME O 2 in response to L-NNA was markedly enhanced by pretreatment with PDE5 inhibition in normal swine but not in MI swine, indicating that PDE5 activity limited the vasodilator influence of NO in normal swine but not in MI swine. Taken together, these observations suggest that downregulation of PDE5 in resistance vessels within the remote myocardium of MI swine served to blunt the loss of NO vasodilator influence.
DISCUSSION
The main findings of the present study are that 1) PDE5 inhibition resulted in coronary resistance vessel dilation both at rest and during exercise; 2) after MI, coronary resistance vessel dilation in the remote myocardium produced by PDE5 inhibition was attenuated; 3) PDE5 gene expression was reduced in coronary small arteries isolated from the remote myocardium after MI; 4) inhibition of eNOS produced coronary vasoconstriction that was only slightly reduced in MI swine compared with normal swine; 5) PDE5 inhibition-induced coronary vasodilation was markedly reduced after prior inhibition of NO synthesis in normal swine, demonstrating that NO is a major activator of cGMP production; and 6) in contrast, in MI swine, PDE5 inhibition was not reduced by prior inhibition of eNOS, suggesting that other factors are responsible for cGMP production. The implications of these findings are discussed below.
Methodological Considerations
To interrogate the regulation of coronary resistance vessel tone, we used systemic administration of pharmacological agents. As a consequence of the agents' systemic effects, perfusion pressure, O 2 -carrying capacity of the blood, and myocardial O 2 demand may change, all of which have indirect effects on coronary resistance vessel tone, thereby potentially confounding the direct effects of these agents and making interpretation of the results difficult. For example, eNOS inhibition resulted in systemic vasoconstriction, thereby increasing arterial pressure and resulting in a decrease in heart rate and contractility. Conversely, PDE5 inhibition caused mild systemic vasodilation, thereby decreasing arterial pressure and resulting in an increase in heart rate and contractility. The effects of changes in pressure and heart rate counterbalanced each other, and hence the overall influence of the systemic effects of eNOS and PDE5 inhibition on MV O 2 did not reach statistical significance. In contrast, the alterations in pressure did result in an autoregulatory response, acting to maintain CBF commensurate with myocardial O 2 demand and contributing at least in part to the observed changes in calculated coronary vascular resistance. In addition, eNOS and PDE5 inhibition produced changes in hemoglobin, particularly during exercise, requiring adjustments in CBF to maintain MD O 2 commensurate with myocardial O 2 demand. These examples illustrate the difficulty in interpreting CBF and coronary vascular resistance data when studying the regulation of coronary resistance vessel tone in awake animals over a wide range of myocardial metabolic activities. To circumvent these confounding influences, and to separate direct from indirect effects of pharmacological agents on vascular tone, the so-called myocardial O 2 balance is often used, i.e., the effect of a pharmacological agent on the relation between MV O 2 and (11, 15, 56) . A parallel shift in these relations represents a vasomotor influence that is similar at rest and during exercise, whereas a rotation represents an increased or decreased effect during exercise (11, 15, 56 2 is not an independent variable. Importantly, another index of myocardial work, the rate-pressure product, is linearly related to MV O 2 , and substitution of the rate-pressure product for MV O 2 as an independent variable yields virtually identical results (data not shown). However, since the heart principally uses aerobic metabolism as its source of energy, MV O 2 would appear to be a more appropriate index of myocardial work. A second concern is that the O 2 dissociation curve is influenced by various factors, including pH, PCO 2 , and NO. This can affect the calculation of MV O 2 , particularly when CV SO 2 is estimated from CV PO 2 , using an assumed O 2 dissociation curve (4, 17) . Importantly, in the present study, MV O 2 was determined using highly accurate and direct measurements of not only CV PO 2 but also of hemoglobin concentration and CV SO 2 , therefore accounting for any potential changes in the O 2 dissociation curve. Finally, a linear relation between MV O 2 and CV PO 2 or CV SO 2 is often assumed, even when this is not apparent from visual inspection (25) . In the present study, we validated the use of linear regression analysis by statistically confirming linearity of all relations between MV O 2 and coronary venous O 2 levels, ME O 2 , as well as MD O 2 .
Another methodological consideration concerns the selectivity of EMD-360527 for PDE5. The balance between the production and breakdown of cGMP contributes to the regulation of resistance vessel tone. cGMP in vascular smooth muscle is produced by sGC, which is primarily activated by NO and carbon monoxide, as well as by membrane-bound or particulate GC (pGC), which is activated upon ligand binding to natriuretic peptide receptors, intestinal peptide receptors, and orphan receptors (38) . In vascular smooth muscle, the enzymes responsible for the degradation of the majority of cGMP are PDE1 and, particularly, PDE5 (46) . These are members of the family of PDEs whose function is to remove cAMP and cGMP from various cell types (5, 22) . PDE5 is predominantly present in vascular smooth muscle and skeletal muscle (7, 60) , although there are some reports of its presence in cardiomyocytes (49) and endothelial cells (24) . PDE5 removes cGMP by hydrolyzing it to 5=-GMP (46) . EMD-360527 demonstrates at least 45-fold selectivity for PDE5 compared with other PDEs. If EMD-360527 had inhibited cAMP-degrading PDEs, this would have increased cAMP in vascular smooth muscle as well as cardiac muscle. We have previously shown that an increase in cAMP through inhibition of the cAMPdegrading enzyme PDE3 results in a small increase in heart rate and a large increase in cardiac contractility as measured through an increase in LV dP/dt max (14) . In the present study, administration of incremental dosages of EMD-360527 resulted in a significant increase in heart rate but a minimal increase in dP/dt max (Fig. 8) , suggesting that the effects of EMD-360527 observed in the present study are indeed mediated through increases in cGMP.
Role of PDE5 in the Regulation of Coronary Resistance Vessel Tone at Rest
Inhibition of PDE5 resulted in coronary vasodilation in both normal and MI swine. Thus, increasing the amount of cGMP in vascular smooth muscle by inhibiting its degradation reduces smooth muscle tone in the coronary microvasculature, as evidenced by an increase in CBF as well as increases in CV PO 2 and CV SO 2 . Moreover, the increase in CBF and hence in MD O 2 of ϳ10% in response to PDE5 inhibition corresponded well with the parallel ϳ10% decrease in ME O 2 measured in our experiments.
Our findings in awake swine are in accordance with observations in anesthetized dogs showing an increase in CBF in response to PDE5 inhibition with sildenafil (35) . Yet, a study (6) in awake dogs showed that, although CBF increased, hemoglobin decreased, resulting in maintenance of MD O 2 . In contrast, hemoglobin concentrations were not affected by PDE5 inhibition in resting swine in the present study ( Table 2 ), such that MD O 2 did increase in parallel with the increase in CBF in response to PDE5 inhibition. The diameter of the large coronary arteries did increase in response to PDE5 inhibition in both humans (29) and swine (1). Yet, human studies have failed to show an increase in CBF (as measured with positron emission tomography or with flow wire) in response to PDE5 inhibition under resting conditions (29, 30, 54, 61) , although PDE5 inhibition did augment adenosine-induced increases in CBF (54) . Importantly, however, all human studies involved patients with (severe) coronary artery disease (CAD), and even though the measurements were performed distal to nondiseased segments, it is likely that these patients had some degree of endothelial dysfunction in the coronary microcirculation (45) that may have limited the response to PDE5 inhibition. Hence, the lower levels of cGMP production could potentially explain the lack of effect of PDE5 inhibition in the coronary microvasculature of CAD patients. In support of this concept, it has been shown that even in patients with mild CAD that showed little effect of PDE5 inhibition under basal conditions, PDE5 inhibition enhanced the NO-mediated vasodilation by acetyl- choline of both large epicardial coronary arteries and the coronary microcirculation (29) . Altogether, PDE5 inhibition has been shown to induce coronary vasodilation in the healthy coronary microcirculation under resting conditions, provided there is a sufficient production of NO and hence cGMP.
Role of PDE5 in the Regulation of Coronary Resistance Vessel Tone During Exercise
In contrast to a study (61) in humans in which the vasodilator effect of PDE5-inhibition increased during increased myocardial work as well as a study (6) in dogs in which the vasodilator effect tended to increase during exercise, the coronary vasodilator effect of PDE5 inhibition slightly decreased during exercise in our porcine model. This finding may be interpreted to suggest that cGMP production decreased during exercise. However, in accordance with previous studies (16, 28) from our laboratory, the effect of eNOS inhibition on coronary vasomotor tone was well maintained during exercise, suggesting that NO-dependent activation of sGC was not altered. Moreover, we have previously shown that plasma levels of atrial natriuretic peptide increased during exercise (27) , making it unlikely that activation of pGC decreased during exercise. A possible explanation for the unexpected observation that the effect of PDE5 inhibition decreases with incremental levels of exercise may be that the exercise-induced reduction in coronary resistance vessel tone blunts the sensitivity of vascular smooth muscle to cGMP. This notion is supported by unpublished observations from our laboratory demonstrating that intravenous infusion of 8-Br-cGMP at a dose of 30 g·kg Ϫ1 ·min Ϫ1 for 10 min had no significant coronary vasodilator effect under control conditions but did result in significant vasodilation, as evidenced by an increase in CV PO 2 (from 21.1 Ϯ 1.3 to 22.9 Ϯ 1.0 mmHg, P Ͻ 0.05) and CV SO 2 (from 11.3 Ϯ 1.0 to 13.1 Ϯ 1.1%, P Ͻ 0.05) in the presence of eNOS blockade. Another potential mechanism behind the blunted effect of PDE5 inhibition during exercise may be through interfering with sympathetic signaling (36) . Thus, cGMP has been shown to blunt norepinephrine release from sympathetic nerve endings in canine vascular smooth muscle (26) and in failing human hearts (2) . In porcine coronary resistance vessels, ␤-adrenergic vasodilation predominates (13, 23) , with little effect of either ␣-blockade or ␣-stimulation on coronary vascular tone (8, 13, 48) . During exercise, when sympathetic activity is high, particularly in the heart (40), PDE5 inhibition could thus have acted to suppress ␤-adrenergic vasodilation, thereby counteracting the direct vasodilator effect of PDE5 inhibition.
Importance of NO Bioavailability for Vasoconstrictor Influence of PDE5
NO is an important stimulus for cGMP production through activation of sGC, such that the vasodilator effect of PDE5 inhibition is thought to be dependent on endogenous NO production by eNOS. This is also illustrated by the observation that the coronary vasodilation by acetylcholine, which is largely NO mediated, is potentiated by PDE5 inhibition (6, 29) .
Decreased NO bioavailability, such as occurs with endothelial dysfunction, is therefore likely to attenuate the effect of PDE5 inhibition. To mimic endothelial dysfunction in the present study, we investigated the effect of PDE5 inhibition after prior eNOS inhibition with L-NNA. In agreement with previous studies (9, 16) from our laboratory, inhibition of eNOS caused coronary vasoconstriction at rest and during exercise. Subsequent PDE5 inhibition resulted in coronary vasodilation that was markedly reduced compared with the vasodilation to PDE5 inhibition under control conditions, indicating that NO is indeed an important activator of cGMP synthesis in the coronary circulation of normal swine. Nevertheless, even in the absence of NO, a significant portion of the coronary vasodilation in response to PDE5 inhibition was still present, suggesting that other factors, such as carbon monoxide and/or atrial natriuretic peptide, contribute to the generation of cGMP through the activation of sGC and pGC, respectively, when NO synthesis is inhibited (38) . Interestingly, after eNOS inhibition, the vasodilation in response to PDE5 inhibition was maintained during exercise, suggesting that NO-independent cGMP levels are not influenced by exercise. This is surprising given our previous observation demonstrating that ANP levels do increase at the highest exercise intensity (27) .
cGMP in the Regulation of Coronary Resistance Vessel Tone After MI
In the present study, PDE5 mRNA expression in coronary small arteries from the remote noninfarcted myocardium was reduced after MI. Although mRNA expression cannot be equated to PDE5 protein level or activity, this finding is consistent with our in vivo observation of a reduced vasoconstrictor influence of PDE5 in the remote myocardium. A reduced vasoconstrictor influence of PDE5 may act to prolong the coronary vasodilator influence of cGMP. This finding has important implications for the interpretation of data on the vasoconstrictor effects of inhibition of NO production. In previous studies from our laboratory, we found that inhibition of eNOS resulted in coronary vasoconstriction that was similar (28) or slightly decreased (9) in swine with MI. In the present study, which involved a large number of normal and MI swine, we confirmed that coronary vasoconstriction after eNOS inhibition was slightly less in swine with MI than in normal swine, suggesting that the NO vasodilator influence was mildly reduced in the remote coronary vasculature after MI. The results from the present study demonstrate that the reduced vasodilator influence of NO was not due to increased PDE5 activity. Rather, the reduced PDE5 gene expression and the blunted vasoconstrictor influence of PDE5 after MI suggest that PDE5 is downregulated to prolong the biological availability of cGMP in an attempt to maintain the vasodilator influence of NO. This implies that the amount of NO required for this vasodilator influence is reduced. This interpretation is also supported by the observation that the vasoconstrictor responses to eNOS inhibition were enhanced by prior PDE5 inhibition in normal but not MI swine. The mechanism responsible for the reduced NO bioavailability was not determined in the present study. However, our recent observation showing that eNOS uncoupling is present in the remote zone after MI (53) suggests that both loss of NO production and reduced half-life of NO, due to scavenging by superoxide, may contribute.
Finally, our observation that the vasodilator effect of PDE5 inhibition in MI swine was maintained in the presence of eNOS inhibition indicates that factors other than NO must have contributed to the generation of cGMP in coronary resistance vessels of MI swine. Indeed, we have shown that plasma levels of ANP are increased in swine with MI (27) , such that the contribution of pGC to the generation of cGMP is likely to be elevated in MI swine. Moreover, our data suggest that, although inhibition of eNOS does result in vasoconstriction in swine with MI, the main vasodilator effect of NO is not mediated by increasing cGMP, as the effect of eNOS inhibition was similar in the presence and absence of PDE5 inhibition. It is likely that the principal vasodilator effect of NO in the remote coronary circulation of swine with MI is mediated through limiting the vasoconstrictor effects of endothelin (43) .
Conclusions
In healthy swine, PDE5 contributes to basal resting coronary resistance vessel tone but does not limit exercise-induced coronary vasodilation. The vasodilator effect of PDE5 inhibition is partially NO dependent. In contrast, in MI swine, the vasodilator effect of PDE5 inhibition in the remote surviving myocardium is NO independent. Furthermore, PDE5 expression is attenuated compared with normal swine, which acts to maintain cGMP-mediated vasodilation in coronary resistance vessels. In combination with previous data from our laboratory, showing attenuation of endothelin type A-and angiotensin II type 1 receptor-mediated vasoconstriction in the remote myocardium after MI (12, 40, 42) , the present study further supports the concept that attenuation of vasoconstrictor pathways serves to maintain coronary perfusion in the remodeled myocardium after MI.
